亚洲AV第二区国产精品,最好的2019中文大全在线观看 ,黄色视频网站在线观看,国产裸体美女永久免费无遮挡
CYC1兔多克隆抗體

CYC1兔多克隆抗體

  • 價格¥1200
  • 規(guī)格50ul
  • 貨號HK210116S
  • 單位
  • 品牌HaoKebio

產(chǎn)品介紹
產(chǎn)品參數(shù)
資料下載
品牌商品編碼商品名稱規(guī)格單位單價
HaoKebioHK210116SCYC1兔多克隆抗體50ul1200

Applications


Tested Applications:
IHC, WB,ELISA

Cited Applications:
IHC, WB
Species Specificity:
human, mouse

Cited Species:
human, monkey, mouse, pig

Positive WB detected in:
human brain tissue

Positive IHC detected in:
human liver cancer tissue, human breast cancer tissue
Note: suggested antigen retrieval with?TE buffer pH 9.0;?(*) Alternatively, antigen retrieval may be performed with?citrate buffer pH 6.0

Recommended dilution:
WB : 1:500-1:2000
IHC : 1:50-1:500
Product Information

Source:
Rabbit

Purification method:
Antigen affinity purification

Isotype:
IgG

Storage:
PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
Store at -20°C. Stable for one year after shipment.?Aliquoting is unnecessary for -20oC storage.
Immunogen Information

Full name:
cytochrome c-1

Calculated molecular weight:
35 kDa

Observed molecular weight:
35 kDa



Gene symbol
CYC1

Synonyms
Complex III subunit 4, Complex III subunit IV, CYC1, cytochrome c 1, UQCR4
Background
CYC1, also named as Cytochrome c-1, belongs to the cytochrome c family. Cytochrome c1 is one respiratory subunit of the 11 subunits of the cytochrome bc1 complex of the mitochondrial electron-transfer chain. It mediates the transfer of an electron from Rieske iron-sulfur protein to cytochrome c(PMID:3036122 ). CYC1 mediates apoptosis. In this pathway, a variety of apoptotic stimuli cause CYC1 release from mitochondria, which in turn induces a series of biochemical reactions that result incaspase activation and subsequent cell death.(PMID:15189137) While CYC1 release and DNA fragmentation are unaffected by the noncleavablep75 mutant, mitochondrial morphology of dying cells is maintained, and loss of plasma membrane integrity is delayed(PMID:15186778). The protein migrated as a 35 kd band in SDS page.

暫無

說明文檔下載

上一篇: 下一篇:

推薦

您好!請登錄

點擊取消回復(fù)
    展開更多
    點擊展開我們的聯(lián)系方式